| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.796 | 0.004 | 0.796 | 5 Hydroxytryptamine release stimulant | 0.752 0.005 CID_124202110 | ||
| 0.616 | 0.011 | 0.616 | Interleukin antagonist | 0.37 0.035 CID_124202110 | ||
| 0.577 | 0.01 | 0.577 | GABA C receptor rho-3 antagonist | |||
| 0.598 | 0.036 | 0.756 | Caspase 9 stimulant | 0.756 0.017 CID_124202110 | CID_124202110 | |
| 0.555 | 0.006 | 0.555 | Peroxidase inhibitor | |||
| 0.55 | 0.003 | 0.55 | GABA C receptor agonist | |||
| 0.548 | 0.017 | 0.548 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.543 | 0.017 | 0.568 | Histamine release inhibitor | 0.568 0.014 CID_124202110 | CID_124202110 | |
| 0.532 | 0.017 | 0.532 | Calcium channel L-type activator | 0.388 0.089 CID_124202110 | ||
| 0.454 | 0.004 | 0.454 | Prostaglandin antagonist | |||
| 0.473 | 0.034 | 0.473 | Vasodilator, peripheral | 0.425 0.048 CID_124202110 | ||
| 0.413 | 0.003 | 0.413 | Phenylalanine 4-hydroxylase inhibitor | 0.076 0.04 CID_124202110 | ||
| 0.441 | 0.031 | 0.441 | Aryl hydrocarbon receptor agonist | 0.158 0.13 CID_124202110 | ||
| 0.413 | 0.004 | 0.413 | Gastrin inhibitor | 0.308 0.028 CID_124202110 | ||
| 0.422 | 0.019 | 0.422 | Insulysin inhibitor | |||
| 0.41 | 0.007 | 0.41 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.402 | 0.024 | 0.402 | Calcium channel activator | |||
| 0.435 | 0.059 | 0.435 | 5 Hydroxytryptamine release inhibitor | 0.386 0.087 CID_124202110 | ||
| 0.379 | 0.004 | 0.379 | Adenylate kinase inhibitor | 0.231 0.012 CID_124202110 | ||
| 0.41 | 0.045 | 0.41 | Aldehyde oxidase inhibitor | |||
| 0.367 | 0.003 | 0.367 | Prostaglandin D2 antagonist | |||
| 0.385 | 0.022 | 0.385 | Sodium/bile acid cotransporter inhibitor | 0.244 0.135 CID_124202110 | ||
| 0.368 | 0.005 | 0.368 | 5 Hydroxytryptamine 1 agonist | |||
| 0.386 | 0.025 | 0.386 | Psychostimulant | 0.26 0.055 CID_124202110 | ||
| 0.389 | 0.03 | 0.498 | Interleukin 2 agonist | 0.498 0.008 CID_124202110 | CID_124202110 | |
| 0.429 | 0.076 | 0.683 | Cyclophilin D inhibitor | 0.683 0.016 CID_124202110 | CID_124202110 | |
| 0.4 | 0.049 | 0.641 | Antithrombotic | 0.641 0.012 CID_124202110 | CID_124202110 | |
| 0.349 | 0.005 | 0.349 | Histidine decarboxylase inhibitor | |||
| 0.357 | 0.013 | 0.357 | Lipocortins synthesis antagonist | 0.269 0.028 CID_124202110 | ||
| 0.341 | 0.018 | 0.399 | DNA methylase inhibitor | 0.399 0.011 CID_124202110 | CID_124202110 | |
| 0.32 | 0.005 | 0.32 | GABA C receptor rho-2 antagonist | |||
| 0.316 | 0.003 | 0.316 | GABA C receptor rho-1 antagonist | |||
| 0.35 | 0.038 | 0.376 | Platelet antagonist | 0.376 0.032 CID_124202110 | CID_124202110 | |
| 0.329 | 0.018 | 0.33 | DNA methyltransferase I inhibitor | 0.33 0.018 CID_124202110 | CID_124202110 | |
| 0.311 | 0.004 | 0.311 | GABA C receptor antagonist | |||
| 0.329 | 0.027 | 0.329 | Growth hormone agonist | 0.129 0.109 CID_124202110 | ||
| 0.307 | 0.007 | 0.307 | Ferrochelatase inhibitor | |||
| 0.296 | 0.004 | 0.296 | Interleukin 8 antagonist | |||
| 0.294 | 0.002 | 0.294 | GABA B receptor agonist | |||
| 0.296 | 0.005 | 0.296 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.311 | 0.023 | 0.311 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.29 | 0.006 | 0.29 | Catalase inhibitor | |||
| 0.278 | 0.003 | 0.278 | DOPA decarboxylase inhibitor | 0.096 0.085 CID_124202110 | ||
| 0.273 | 0.004 | 0.273 | Prolactin inhibitor | |||
| 0.269 | 0.006 | 0.269 | Porphobilinogen synthase inhibitor | |||
| 0.28 | 0.018 | 0.34 | Alpha-N-acetylglucosaminidase inhibitor | 0.34 0.013 CID_124202110 | CID_124202110 | |
| 0.259 | 0.004 | 0.259 | Cholecystokinin antagonist | |||
| 0.299 | 0.048 | 0.373 | Interleukin agonist | 0.373 0.023 CID_124202110 | CID_124202110 | |
| 0.253 | 0.007 | 0.344 | Triose-phosphate isomerase inhibitor | 0.344 0.004 CID_124202110 | CID_124202110 | |
| 0.388 | 0.147 | 0.769 | Antiinflammatory | 0.769 0.02 CID_124202110 | CID_124202110 | |
| 0.289 | 0.051 | 0.289 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.245 | 0.007 | 0.254 | CF transmembrane conductance regulator agonist | 0.254 0.005 CID_124202110 | CID_124202110 | |
| 0.291 | 0.054 | 0.291 | Superoxide dismutase inhibitor | |||
| 0.238 | 0.006 | 0.238 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.327 | 0.095 | 0.327 | Toll-Like receptor agonist | |||
| 0.258 | 0.028 | 0.258 | Nitric-oxide synthase stimulant | 0.243 0.037 CID_124202110 | ||
| 0.249 | 0.021 | 0.249 | Neurotensin receptor agonist | |||
| 0.28 | 0.053 | 0.28 | Pyruvate kinase inhibitor | |||
| 0.323 | 0.097 | 0.323 | Toll-Like receptor 7 agonist | |||
| 0.254 | 0.032 | 0.254 | Insulin sensitizer | 0.155 0.127 CID_124202110 | ||
| 0.223 | 0.004 | 0.223 | Cholecystokinin A antagonist | |||
| 0.272 | 0.054 | 0.278 | Cyclic AMP phosphodiesterase inhibitor | 0.278 0.051 CID_124202110 | CID_124202110 | |
| 0.224 | 0.009 | 0.251 | Photosensitizer | 0.251 0.006 CID_124202110 | CID_124202110 | |
| 0.226 | 0.014 | 0.226 | Toll-Like receptor 2 antagonist | 0.122 0.076 CID_124202110 | ||
| 0.221 | 0.014 | 0.221 | GABA receptor agonist | |||
| 0.32 | 0.118 | 0.32 | 15-Lipoxygenase inhibitor | |||
| 0.212 | 0.012 | 0.212 | 5 Hydroxytryptamine 3A agonist | |||
| 0.279 | 0.08 | 0.279 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.282 | 0.084 | 0.578 | Immunostimulant | 0.578 0.019 CID_124202110 | CID_124202110 | |
| 0.242 | 0.046 | 0.419 | Non-steroidal antiinflammatory agent | 0.419 0.011 CID_124202110 | CID_124202110 | |
| 0.226 | 0.032 | 0.226 | Succinate dehydrogenase inhibitor | |||
| 0.266 | 0.072 | 0.382 | DNA damaging | 0.382 0.033 CID_124202110 | CID_124202110 | |
| 0.203 | 0.01 | 0.431 | AMP-activated protein kinase stimulant | 0.431 0.004 CID_124202110 | CID_124202110 | |
| 0.223 | 0.032 | 0.223 | Phospholipase A2 inhibitor | 0.164 0.063 CID_124202110 | ||
| 0.243 | 0.054 | 0.243 | Anesthetic general | 0.196 0.076 CID_124202110 | ||
| 0.192 | 0.005 | 0.192 | Myeloperoxidase inhibitor | |||
| 0.241 | 0.056 | 0.241 | Platelet aggregation inhibitor | |||
| 0.196 | 0.015 | 0.196 | Adenylate cyclase stimulant | 0.154 0.056 CID_124202110 | ||
| 0.195 | 0.015 | 0.195 | 5 Hydroxytryptamine agonist | |||
| 0.184 | 0.004 | 0.184 | Cholecystokinin B antagonist | |||
| 0.249 | 0.07 | 0.677 | Angiogenesis stimulant | 0.677 0.005 CID_124202110 | CID_124202110 | |
| 0.195 | 0.016 | 0.195 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.182 0.019 CID_124202110 | ||
| 0.209 | 0.032 | 0.209 | NADPH oxidase inhibitor | 0.165 0.046 CID_124202110 | ||
| 0.18 | 0.007 | 0.18 | Histamine N-methyltransferase inhibitor | |||
| 0.203 | 0.03 | 0.203 | Catenin beta inhibitor | |||
| 0.205 | 0.033 | 0.242 | ATPase inhibitor | 0.242 0.016 CID_124202110 | CID_124202110 | |
| 0.192 | 0.021 | 0.192 | Nav1.4 sodium channel blocker | |||
| 0.204 | 0.034 | 0.228 | Insulin secretagoues | 0.228 0.025 CID_124202110 | CID_124202110 | |
| 0.196 | 0.026 | 0.196 | Adenylate cyclase inhibitor | 0.118 0.069 CID_124202110 | ||
| 0.215 | 0.045 | 0.33 | Thrombolytic | 0.33 0.019 CID_124202110 | CID_124202110 | |
| 0.292 | 0.122 | 0.292 | Antiobesity | |||
| 0.201 | 0.032 | 0.201 | Arachidonic acid antagonist | |||
| 0.172 | 0.004 | 0.172 | GABA B receptor antagonist | |||
| 0.19 | 0.024 | 0.19 | Aminopeptidase B inhibitor | |||
| 0.177 | 0.018 | 0.177 | NMDA receptor antagonist | |||
| 0.235 | 0.078 | 0.349 | DNA synthesis inhibitor | 0.349 0.03 CID_124202110 | CID_124202110 | |
| 0.176 | 0.02 | 0.231 | Mediator release inhibitor | 0.231 0.011 CID_124202110 | CID_124202110 | |
| 0.224 | 0.07 | 0.224 | RNA-directed DNA polymerase inhibitor | 0.196 0.105 CID_124202110 | ||
| 0.268 | 0.115 | 0.686 | Transcription factor NF kappa B inhibitor | 0.686 0.022 CID_124202110 | CID_124202110 | |
| 0.265 | 0.113 | 0.49 | Apoptosis antagonist | 0.49 0.022 CID_124202110 | CID_124202110 | |
| 0.155 | 0.004 | 0.155 | AMPA 4 receptor antagonist | |||
| 0.154 | 0.004 | 0.154 | AMPA 1 receptor antagonist | |||
| 0.17 | 0.022 | 0.17 | Protein kinase C gamma inhibitor | 0.115 0.057 CID_124202110 | ||
| 0.159 | 0.012 | 0.159 | Glutamate decarboxylase inhibitor | |||
| 0.149 | 0.004 | 0.149 | 5 Hydroxytryptamine 1B agonist | |||
| 0.163 | 0.019 | 0.173 | Ca2+-transporting ATPase inhibitor | 0.173 0.011 CID_124202110 | CID_124202110 | |
| 0.151 | 0.007 | 0.181 | Glycine receptor antagonist | 0.181 0.004 CID_124202110 | CID_124202110 | |
| 0.216 | 0.072 | 0.216 | Anticonvulsant | |||
| 0.174 | 0.031 | 0.292 | Cyclooxygenase 3 inhibitor | 0.292 0.006 CID_124202110 | CID_124202110 | |
| 0.147 | 0.005 | 0.147 | Kainate receptor antagonist | |||
| 0.183 | 0.042 | 0.183 | Cyclooxygenase 1 inhibitor | 0.136 0.066 CID_124202110 | ||
| 0.173 | 0.033 | 0.186 | Interleukin 4 antagonist | 0.186 0.027 CID_124202110 | CID_124202110 | |
| 0.147 | 0.01 | 0.147 | Bombesin 2 receptor antagonist | |||
| 0.144 | 0.009 | 0.144 | NMDA receptor agonist | |||
| 0.185 | 0.051 | 0.185 | Interleukin 6 antagonist | 0.165 0.069 CID_124202110 | ||
| 0.14 | 0.007 | 0.14 | NMDA receptor subunit 3B antagonist | |||
| 0.163 | 0.031 | 0.163 | Falcipain 3 inhibitor | |||
| 0.142 | 0.011 | 0.142 | Alcohol oxidase inhibitor | |||
| 0.156 | 0.026 | 0.156 | Potassium channel (Ca-activated) activator | |||
| 0.143 | 0.015 | 0.143 | Somatostatin 1 agonist | 0.09 0.042 CID_124202110 | ||
| 0.134 | 0.007 | 0.134 | AMPA receptor antagonist | |||
| 0.158 | 0.031 | 0.158 | Heat shock protein 70 antagonist | 0.145 0.059 CID_124202110 | ||
| 0.163 | 0.037 | 0.176 | Antibacterial (Helicobacter pylori) | 0.176 0.03 CID_124202110 | CID_124202110 | |
| 0.165 | 0.04 | 0.165 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.136 | 0.016 | 0.136 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.173 | 0.055 | 0.173 | Cyclooxygenase inhibitor | 0.136 0.082 CID_124202110 | ||
| 0.166 | 0.048 | 0.166 | Interleukin 1 antagonist | |||
| 0.131 | 0.013 | 0.131 | Bile acid receptor antagonist | |||
| 0.159 | 0.042 | 0.159 | Aldehyde dehydrogenase inhibitor | 0.104 0.092 CID_124202110 | ||
| 0.148 | 0.032 | 0.148 | TRPA1 agonist | 0.096 0.095 CID_124202110 | ||
| 0.129 | 0.014 | 0.129 | Argininosuccinate synthase inhibitor | 0.052 0.044 CID_124202110 | ||
| 0.136 | 0.022 | 0.136 | ABCA1 expression enhancer | |||
| 0.179 | 0.066 | 0.179 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.12 | 0.007 | 0.12 | NMDA receptor subunit 3A antagonist | |||
| 0.116 | 0.004 | 0.116 | AMPA 3 receptor antagonist | |||
| 0.205 | 0.094 | 0.539 | Free radical scavenger | 0.539 0.013 CID_124202110 | CID_124202110 | |
| 0.136 | 0.025 | 0.136 | Alcohol dehydrogenase inhibitor | |||
| 0.115 | 0.004 | 0.115 | MDM2 inhibitor | |||
| 0.125 | 0.015 | 0.125 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.114 | 0.004 | 0.114 | Kainate receptor 2 antagonist | |||
| 0.119 | 0.009 | 0.119 | 5 Hydroxytryptamine 2A agonist | |||
| 0.14 | 0.03 | 0.58 | Beta glucuronidase inhibitor | 0.58 0.003 CID_124202110 | CID_124202110 | |
| 0.166 | 0.057 | 0.333 | Amylase inhibitor | 0.333 0.014 CID_124202110 | CID_124202110 | |
| 0.211 | 0.103 | 0.211 | Calpain inhibitor | |||
| 0.133 | 0.027 | 0.133 | Electrolyte absorption antagonist | |||
| 0.112 | 0.007 | 0.112 | Aconitate hydratase inhibitor | |||
| 0.167 | 0.062 | 0.22 | Melanin inhibitor | 0.22 0.034 CID_124202110 | CID_124202110 | |
| 0.146 | 0.042 | 0.146 | Cystathionine beta-synthase inhibitor | |||
| 0.238 | 0.134 | 0.419 | Cholesterol antagonist | 0.419 0.046 CID_124202110 | CID_124202110 | |
| 0.202 | 0.098 | 0.336 | Antiamyloidogenic | 0.336 0.042 CID_124202110 | CID_124202110 | |
| 0.13 | 0.027 | 0.13 | Protein kinase C zeta inhibitor | |||
| 0.126 | 0.023 | 0.126 | Adrenaline agonist | |||
| 0.134 | 0.032 | 0.134 | Creatine kinase inhibitor | |||
| 0.232 | 0.13 | 0.522 | Immunomodulator | 0.522 0.02 CID_124202110 | CID_124202110 | |
| 0.115 | 0.015 | 0.115 | Biliverdin reductase inhibitor | |||
| 0.114 | 0.014 | 0.114 | Bombesin 1 receptor agonist | |||
| 0.188 | 0.089 | 0.188 | Neurotrophic factor enhancer | 0.162 0.121 CID_124202110 | ||
| 0.159 | 0.06 | 0.159 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.17 | 0.072 | 0.17 | Phospholipase C inhibitor | |||
| 0.205 | 0.108 | 0.498 | Hypoglycemic | 0.498 0.015 CID_124202110 | CID_124202110 | |
| 0.119 | 0.024 | 0.119 | Interleukin 5 antagonist | 0.089 0.056 CID_124202110 | ||
| 0.098 | 0.004 | 0.098 | Melatonin receptor 1A agonist | |||
| 0.107 | 0.013 | 0.107 | NMDA receptor glycine site agonist | |||
| 0.107 | 0.014 | 0.107 | GABA receptor antagonist | |||
| 0.115 | 0.023 | 0.115 | Keratolytic | |||
| 0.108 | 0.016 | 0.108 | Aldose reductase inhibitor | 0.056 0.034 CID_124202110 | ||
| 0.104 | 0.014 | 0.104 | Endothelin-converting enzyme inhibitor | |||
| 0.108 | 0.017 | 0.108 | Prostaglandin EP2 antagonist | |||
| 0.093 | 0.004 | 0.093 | Kainate receptor 1 antagonist | |||
| 0.178 | 0.089 | 0.178 | Growth factor agonist | |||
| 0.105 | 0.017 | 0.105 | Carbonic anhydrase stimulant | |||
| 0.18 | 0.093 | 0.18 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.126 | 0.04 | 0.385 | UDP-glucose 4-epimerase inhibitor | 0.385 0.006 CID_124202110 | CID_124202110 | |
| 0.176 | 0.091 | 0.176 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.165 | 0.079 | 0.165 | Dual specificity phosphatase inhibitor | |||
| 0.186 | 0.102 | 0.186 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.103 | 0.021 | 0.103 | Neutrophil collagenase inhibitor | |||
| 0.105 | 0.025 | 0.117 | Interferon agonist | 0.117 0.018 CID_124202110 | CID_124202110 | |
| 0.153 | 0.074 | 0.245 | Interferon gamma antagonist | 0.245 0.029 CID_124202110 | CID_124202110 | |
| 0.114 | 0.035 | 0.114 | Interleukin 12 antagonist | 0.104 0.048 CID_124202110 | ||
| 0.137 | 0.057 | 0.137 | Cathepsin H inhibitor | |||
| 0.088 | 0.008 | 0.088 | DNA helicase inhibitor | |||
| 0.085 | 0.006 | 0.085 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.209 | 0.131 | 0.209 | Lipoxygenase inhibitor | |||
| 0.094 | 0.016 | 0.094 | Beta 3 adrenoreceptor antagonist | |||
| 0.214 | 0.136 | 0.214 | Hypoxia-inducible factor 1 alpha inhibitor | 0.187 0.169 CID_124202110 | ||
| 0.088 | 0.011 | 0.088 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.106 | 0.029 | 0.106 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.171 | 0.094 | 0.171 | Amyloid beta aggregation inhibitor | 0.156 0.103 CID_124202110 | ||
| 0.094 | 0.018 | 0.094 | GABA A receptor antagonist | |||
| 0.107 | 0.032 | 0.107 | GABA A receptor agonist | |||
| 0.093 | 0.018 | 0.093 | NMDA 2C receptor antagonist | |||
| 0.104 | 0.03 | 0.104 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.101 | 0.027 | 0.367 | Selectin antagonist | 0.367 0.004 CID_124202110 | CID_124202110 | |
| 0.101 | 0.027 | 0.101 | CDC25A inhibitor | |||
| 0.114 | 0.041 | 0.114 | Protein kinase C delta inhibitor | |||
| 0.114 | 0.041 | 0.114 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.1 | 0.028 | 0.1 | Aminopeptidase I inhibitor | |||
| 0.109 | 0.037 | 0.109 | Aminoacyl-tRNA synthetase inhibitor | 0.081 0.075 CID_124202110 | ||
| 0.146 | 0.074 | 0.319 | Hemostatic | 0.319 0.014 CID_124202110 | CID_124202110 | |
| 0.092 | 0.02 | 0.092 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.102 | 0.03 | 0.102 | Glutamate dehydrogenase inhibitor | |||
| 0.075 | 0.005 | 0.075 | Bombesin 1 receptor antagonist | 0.033 0.031 CID_124202110 | ||
| 0.081 | 0.011 | 0.081 | Thromboxane synthase inhibitor | |||
| 0.078 | 0.008 | 0.078 | Cholecystokinin B agonist | |||
| 0.101 | 0.031 | 0.164 | Phosphofructokinase-1 inhibitor | 0.164 0.016 CID_124202110 | CID_124202110 | |
| 0.088 | 0.018 | 0.099 | Interferon inducer | 0.099 0.013 CID_124202110 | CID_124202110 | |
| 0.073 | 0.004 | 0.073 | Free fatty acid receptor 1 antagonist | |||
| 0.086 | 0.018 | 0.091 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.091 0.016 CID_124202110 | CID_124202110 | |
| 0.106 | 0.038 | 0.212 | NADH dehydrogenase inhibitor | 0.212 0.01 CID_124202110 | CID_124202110 | |
| 0.162 | 0.094 | 0.39 | Platelet adhesion inhibitor | 0.39 0.013 CID_124202110 | CID_124202110 | |
| 0.104 | 0.036 | 0.104 | Metalloproteinase-2 inhibitor | |||
| 0.102 | 0.035 | 0.102 | CYP2A6 inhibitor | |||
| 0.115 | 0.048 | 0.115 | Gastric antisecretory | |||
| 0.085 | 0.018 | 0.085 | NMDA 2A receptor antagonist | |||
| 0.09 | 0.024 | 0.09 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.115 | 0.05 | 0.115 | Urease inhibitor | |||
| 0.107 | 0.043 | 0.107 | Antineoplastic alkaloid | |||
| 0.073 | 0.01 | 0.073 | Thymidylate synthase inhibitor | |||
| 0.067 | 0.004 | 0.067 | Thyroid hormone agonist | |||
| 0.1 | 0.037 | 0.1 | Factor XII inhibitor | |||
| 0.086 | 0.023 | 0.086 | 5 Hydroxytryptamine 3 agonist | |||
| 0.073 | 0.011 | 0.073 | Bombesin antagonist | |||
| 0.09 | 0.028 | 0.09 | Glucagon-like peptide 1 agonist | |||
| 0.116 | 0.054 | 0.133 | Acetylcholine release stimulant | 0.133 0.031 CID_124202110 | CID_124202110 | |
| 0.135 | 0.073 | 0.135 | Nav1.6 sodium channel blocker | |||
| 0.068 | 0.006 | 0.068 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.072 | 0.011 | 0.072 | Somatostatin 1 antagonist | 0.053 0.018 CID_124202110 | ||
| 0.066 | 0.005 | 0.066 | Cholecystokinin agonist | |||
| 0.139 | 0.079 | 0.139 | MAP3K9 inhibitor | |||
| 0.111 | 0.051 | 0.111 | Carbonic anhydrase III inhibitor | |||
| 0.186 | 0.126 | 0.593 | Antioxidant | 0.593 0.012 CID_124202110 | CID_124202110 | |
| 0.072 | 0.013 | 0.072 | Leukotriene C antagonist | |||
| 0.084 | 0.025 | 0.084 | CDC25B inhibitor | 0.082 0.026 CID_124202110 | ||
| 0.124 | 0.065 | 0.124 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.097 | 0.039 | 0.097 | Hematopoietic | |||
| 0.116 | 0.058 | 0.116 | Mucolytic | 0.11 0.064 CID_124202110 | ||
| 0.064 | 0.005 | 0.064 | Kainate receptor agonist | |||
| 0.07 | 0.012 | 0.133 | Heparanase inhibitor | 0.133 0.003 CID_124202110 | CID_124202110 | |
| 0.143 | 0.086 | 0.155 | Protein-tyrosine phosphatase inhibitor | 0.155 0.073 CID_124202110 | CID_124202110 | |
| 0.142 | 0.084 | 0.142 | Diuretic | |||
| 0.108 | 0.052 | 0.108 | Folate antagonist | |||
| 0.133 | 0.077 | 0.133 | Neurotrophic factor | 0.118 0.099 CID_124202110 | ||
| 0.12 | 0.065 | 0.12 | Cholesterol synthesis inhibitor | |||
| 0.08 | 0.025 | 0.08 | Glutamate (mGluR6) antagonist | |||
| 0.127 | 0.073 | 0.127 | Cyclooxygenase 2 inhibitor | |||
| 0.068 | 0.013 | 0.068 | Immunoglobulin Fc receptor antagonist | |||
| 0.118 | 0.064 | 0.118 | Protein kinase (CK2) alpha inhibitor | |||
| 0.091 | 0.037 | 0.091 | Metalloproteinase-9 inhibitor | |||
| 0.24 | 0.186 | 0.648 | Antibacterial | 0.648 0.013 CID_124202110 | CID_124202110 | |
| 0.075 | 0.022 | 0.075 | Beta 1 adrenoreceptor antagonist | |||
| 0.13 | 0.077 | 0.13 | Bone formation stimulant | 0.11 0.095 CID_124202110 | ||
| 0.072 | 0.019 | 0.072 | Prolactin release inhibitor | |||
| 0.061 | 0.008 | 0.061 | p53 inhibitor | |||
| 0.103 | 0.051 | 0.103 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.061 | 0.009 | 0.061 | AMPA 2 receptor antagonist | |||
| 0.09 | 0.038 | 0.09 | Cathepsin G inhibitor | |||
| 0.19 | 0.138 | 0.19 | Neuropeptide Y2 antagonist | |||
| 0.075 | 0.023 | 0.075 | Thromboxane antagonist | |||
| 0.06 | 0.008 | 0.06 | 5 Hydroxytryptamine 1D agonist | |||
| 0.118 | 0.067 | 0.118 | Proteasome inhibitor | |||
| 0.063 | 0.012 | 0.063 | GHS receptor agonist | |||
| 0.065 | 0.015 | 0.065 | Adenylate cyclase 1 inhibitor | |||
| 0.06 | 0.01 | 0.06 | Somatostatin 5 antagonist | 0.04 0.018 CID_124202110 | ||
| 0.078 | 0.03 | 0.078 | Glutamate (mGluR7) antagonist | |||
| 0.057 | 0.009 | 0.057 | Endothelin receptor antagonist | |||
| 0.069 | 0.022 | 0.069 | Thromboxane A2 antagonist | |||
| 0.077 | 0.03 | 0.077 | Beta adrenoreceptor antagonist | |||
| 0.059 | 0.012 | 0.059 | Somatostatin 2 antagonist | 0.03 0.02 CID_124202110 | ||
| 0.081 | 0.033 | 0.081 | Phospholipase D inhibitor | |||
| 0.053 | 0.006 | 0.053 | GHS receptor antagonist | |||
| 0.131 | 0.085 | 0.264 | Cell wall synthesis inhibitor | 0.264 0.014 CID_124202110 | CID_124202110 | |
| 0.071 | 0.024 | 0.071 | Bombesin 3 receptor antagonist | |||
| 0.09 | 0.045 | 0.09 | D-Ala-D-Ala ligase inhibitor | |||
| 0.054 | 0.009 | 0.054 | Integrin alpha2 antagonist | |||
| 0.064 | 0.02 | 0.064 | Beta 2 adrenoreceptor antagonist | |||
| 0.06 | 0.016 | 0.06 | Growth hormone release inhibitor | 0.038 0.034 CID_124202110 | ||
| 0.052 | 0.009 | 0.052 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.058 | 0.015 | 0.058 | Glutamate (mGluR4) antagonist | |||
| 0.055 | 0.012 | 0.055 | Somatostatin agonist | |||
| 0.053 | 0.011 | 0.053 | Somatostatin 5 agonist | |||
| 0.048 | 0.006 | 0.048 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.074 | 0.032 | 0.074 | Aryl hydrocarbon receptor antagonist | |||
| 0.056 | 0.015 | 0.056 | Liver X receptor alpha agonist | |||
| 0.069 | 0.029 | 0.069 | Cyclin D1 inhibitor | |||
| 0.044 | 0.004 | 0.044 | Follicle-stimulating hormone antagonist | |||
| 0.061 | 0.021 | 0.061 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.136 | 0.096 | 0.136 | MAP kinase kinase 4 inhibitor | |||
| 0.044 | 0.005 | 0.044 | Bombesin agonist | |||
| 0.044 | 0.005 | 0.044 | Cholecystokinin A agonist | |||
| 0.064 | 0.025 | 0.064 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.052 | 0.014 | 0.052 | Somatostatin 4 agonist | |||
| 0.156 | 0.12 | 0.156 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.048 | 0.012 | 0.048 | Leukotriene C4 antagonist | |||
| 0.054 | 0.018 | 0.054 | AICAR transformylase inhibitor | |||
| 0.063 | 0.027 | 0.063 | 5 Hydroxytryptamine 7 agonist | |||
| 0.061 | 0.024 | 0.061 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.062 | 0.027 | 0.062 | GP IIb/IIIa receptor antagonist | |||
| 0.051 | 0.016 | 0.051 | Beta adrenoreceptor agonist | |||
| 0.124 | 0.089 | 0.152 | Protein kinase stimulant | 0.152 0.067 CID_124202110 | CID_124202110 | |
| 0.094 | 0.059 | 0.11 | Uric acid excretion stimulant | 0.11 0.044 CID_124202110 | CID_124202110 | |
| 0.087 | 0.052 | 0.087 | Glutathione S-transferase inhibitor | |||
| 0.049 | 0.015 | 0.049 | Retinoid X alpha receptor agonist | |||
| 0.109 | 0.075 | 0.225 | Cell adhesion inhibitor | 0.225 0.019 CID_124202110 | CID_124202110 | |
| 0.038 | 0.004 | 0.038 | ICAM 1 antagonist | |||
| 0.084 | 0.05 | 0.084 | CC chemokine 5 receptor agonist | |||
| 0.065 | 0.031 | 0.065 | Botulinum neurotoxin type A inhibitor | |||
| 0.096 | 0.063 | 0.137 | Xanthine oxidase inhibitor | 0.137 0.04 CID_124202110 | CID_124202110 | |
| 0.131 | 0.098 | 0.234 | Anticoagulant | 0.234 0.042 CID_124202110 | CID_124202110 | |
| 0.041 | 0.008 | 0.041 | NMDA receptor glycine site antagonist | |||
| 0.065 | 0.032 | 0.065 | Beta 2 adrenoreceptor agonist | |||
| 0.12 | 0.088 | 0.12 | Vanilloid 1 agonist | 0.114 0.103 CID_124202110 | ||
| 0.05 | 0.018 | 0.05 | Histone deacetylase 7 inhibitor | |||
| 0.133 | 0.102 | 0.133 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.056 | 0.024 | 0.056 | Adenosine deaminase inhibitor | 0.052 0.029 CID_124202110 | ||
| 0.079 | 0.048 | 0.079 | MAP kinase kinase 7 inhibitor | |||
| 0.067 | 0.036 | 0.067 | Prostaglandin F2 alpha antagonist | |||
| 0.084 | 0.053 | 0.084 | Carbonic anhydrase VI inhibitor | |||
| 0.044 | 0.013 | 0.044 | Melatonin 1 agonist | |||
| 0.051 | 0.02 | 0.051 | Histamine H2 receptor agonist | |||
| 0.046 | 0.015 | 0.046 | Glutamate (mGluR8) agonist | |||
| 0.042 | 0.012 | 0.042 | Liver X receptor beta antagonist | |||
| 0.045 | 0.015 | 0.045 | RNA-directed RNA polymerase inhibitor | |||
| 0.035 | 0.005 | 0.035 | Bombesin 3 receptor agonist | |||
| 0.051 | 0.021 | 0.051 | Geranyltranstransferase inhibitor | |||
| 0.038 | 0.008 | 0.038 | Follicle-stimulating hormone agonist | |||
| 0.054 | 0.024 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.064 0.015 CID_124202110 | CID_124202110 | |
| 0.072 | 0.043 | 0.072 | Protein kinase C beta inhibitor | |||
| 0.146 | 0.117 | 0.146 | Death-associated protein kinase 2 inhibitor | |||
| 0.075 | 0.046 | 0.075 | Glycine receptor agonist | |||
| 0.06 | 0.032 | 0.06 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.102 | 0.074 | 0.296 | Monophenol monooxygenase inhibitor | 0.296 0.018 CID_124202110 | CID_124202110 | |
| 0.038 | 0.01 | 0.038 | Liver X receptor alpha antagonist | |||
| 0.094 | 0.066 | 0.128 | Phosphodiesterase 6D inhibitor | 0.128 0.019 CID_124202110 | CID_124202110 | |
| 0.043 | 0.015 | 0.043 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.069 | 0.041 | 0.069 | Leukotriene antagonist | |||
| 0.031 | 0.005 | 0.031 | Thyroid hormone alpha antagonist | |||
| 0.121 | 0.095 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.067 | 0.041 | 0.067 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.072 | 0.046 | 0.072 | HIV-1 integrase inhibitor | |||
| 0.046 | 0.021 | 0.046 | Urate transporter 1 inhibitor | |||
| 0.048 | 0.023 | 0.048 | Glutamate (mGluR group III) antagonist | |||
| 0.064 | 0.038 | 0.064 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.036 | 0.011 | 0.036 | Kainate receptor 4 antagonist | |||
| 0.198 | 0.172 | 0.198 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.054 | 0.029 | 0.054 | Antimetabolite | 0.051 0.031 CID_124202110 | ||
| 0.064 | 0.04 | 0.064 | Caspase 9 inhibitor | |||
| 0.039 | 0.015 | 0.039 | Prostaglandin EP3 antagonist | |||
| 0.035 | 0.012 | 0.035 | Urotensin II agonist | |||
| 0.035 | 0.011 | 0.035 | 5 Hydroxytryptamine 6 agonist | |||
| 0.057 | 0.034 | 0.057 | Ornithine carbamoyltransferase inhibitor | |||
| 0.038 | 0.015 | 0.038 | HCV NS5B polymerase inhibitor | |||
| 0.039 | 0.016 | 0.039 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.072 | 0.049 | 0.072 | NMDA 2 receptor antagonist | |||
| 0.039 | 0.017 | 0.039 | Carnitine palmitoyltransferase inhibitor | |||
| 0.025 | 0.003 | 0.025 | Thyroid hormone beta agonist | |||
| 0.043 | 0.021 | 0.043 | Histone deacetylase 9 inhibitor | |||
| 0.06 | 0.038 | 0.06 | Glutamate (mGluR1) antagonist | |||
| 0.04 | 0.019 | 0.04 | Fumarate hydratase inhibitor | |||
| 0.076 | 0.054 | 0.076 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.104 | 0.083 | 0.187 | Microtubule formation inhibitor | 0.187 0.023 CID_124202110 | CID_124202110 | |
| 0.042 | 0.021 | 0.042 | Retinoid X receptor antagonist | |||
| 0.025 | 0.005 | 0.025 | Thyroid hormone alpha agonist | |||
| 0.046 | 0.025 | 0.046 | Toll-Like receptor 2 agonist | 0.045 0.026 CID_124202110 | ||
| 0.031 | 0.011 | 0.031 | Integrin alpha2beta1 antagonist | |||
| 0.035 | 0.016 | 0.035 | Glucagon receptor antagonist | |||
| 0.045 | 0.026 | 0.045 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.038 | 0.019 | 0.038 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.049 | 0.031 | 0.086 | Phosphorylase inhibitor | 0.086 0.015 CID_124202110 | CID_124202110 | |
| 0.104 | 0.085 | 0.104 | Caspase 3 inhibitor | |||
| 0.037 | 0.019 | 0.037 | Retinoid X alpha receptor antagonist | |||
| 0.03 | 0.012 | 0.03 | Somatostatin 4 antagonist | 0.027 0.013 CID_124202110 | ||
| 0.038 | 0.019 | 0.038 | Prostacyclin antagonist | |||
| 0.098 | 0.08 | 0.123 | Protein-tyrosine phosphatase 1B inhibitor | 0.123 0.061 CID_124202110 | CID_124202110 | |
| 0.189 | 0.171 | 0.189 | Thyroid hormone antagonist | |||
| 0.039 | 0.022 | 0.039 | Glutamate (mGluR3) antagonist | |||
| 0.033 | 0.016 | 0.033 | Uridine phosphorylase inhibitor | 0.033 0.015 CID_124202110 | ||
| 0.067 | 0.05 | 0.067 | Carbonic anhydrase VA inhibitor | |||
| 0.036 | 0.019 | 0.036 | Melatonin agonist | |||
| 0.04 | 0.023 | 0.04 | Retinoid X receptor agonist | |||
| 0.046 | 0.029 | 0.046 | Complement C3a chemotactic receptor antagonist | |||
| 0.027 | 0.01 | 0.027 | Somatostatin 3 antagonist | 0.018 0.017 CID_124202110 | ||
| 0.059 | 0.042 | 0.059 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.034 | 0.018 | 0.034 | Liver X receptor antagonist | |||
| 0.027 | 0.011 | 0.027 | Endothelin A receptor antagonist | |||
| 0.107 | 0.091 | 0.107 | M17 leucyl aminopeptidase inhibitor | |||
| 0.048 | 0.032 | 0.048 | Aldosterone antagonist | |||
| 0.075 | 0.059 | 0.075 | Macrophage migration inhibitory factor inhibitor | |||
| 0.039 | 0.023 | 0.039 | Growth hormone secretagogue receptor antagonist | |||
| 0.033 | 0.018 | 0.033 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.029 | 0.014 | 0.029 | Prostaglandin H2 antagonist | |||
| 0.022 | 0.007 | 0.022 | Somatostatin 3 agonist | |||
| 0.045 | 0.03 | 0.045 | Sphingosine 1-phosphate receptor agonist | |||
| 0.165 | 0.15 | 0.201 | Spasmolytic | 0.201 0.119 CID_124202110 | CID_124202110 | |
| 0.028 | 0.013 | 0.028 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.019 | 0.005 | 0.019 | Integrin beta2 antagonist | |||
| 0.057 | 0.042 | 0.057 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.072 | 0.058 | 0.072 | GABA aminotransferase inhibitor | 0.068 0.064 CID_124202110 | ||
| 0.021 | 0.007 | 0.021 | Complement factor D inhibitor | |||
| 0.132 | 0.118 | 0.132 | LIM domain kinase 1 inhibitor | |||
| 0.043 | 0.03 | 0.043 | Integrin antagonist | |||
| 0.037 | 0.024 | 0.037 | Nicotinic acid receptor agonist | |||
| 0.057 | 0.045 | 0.057 | Androgen agonist | |||
| 0.025 | 0.012 | 0.025 | Kainate receptor 5 antagonist | |||
| 0.047 | 0.035 | 0.047 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.063 | 0.051 | 0.063 | Matrix metalloproteinase inhibitor | |||
| 0.049 | 0.037 | 0.049 | CD45 antagonist | |||
| 0.026 | 0.015 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.043 | 0.032 | 0.043 | Dihydrofolate reductase inhibitor | |||
| 0.1 | 0.089 | 0.145 | Beta amyloid protein antagonist | 0.145 0.044 CID_124202110 | CID_124202110 | |
| 0.055 | 0.045 | 0.055 | Pregnane X receptor antagonist | |||
| 0.061 | 0.05 | 0.061 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.129 | 0.119 | 0.129 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.019 | 0.009 | 0.019 | Kainate receptor 3 antagonist | |||
| 0.033 | 0.023 | 0.033 | Liver X receptor beta agonist | |||
| 0.037 | 0.027 | 0.037 | Melanocortin 1 antagonist | |||
| 0.035 | 0.026 | 0.035 | Glutamate (mGluR8) antagonist | |||
| 0.09 | 0.081 | 0.21 | Expectorant | 0.21 0.018 CID_124202110 | CID_124202110 | |
| 0.024 | 0.015 | 0.024 | Retinoid X gamma receptor agonist | |||
| 0.032 | 0.024 | 0.032 | Carboxypeptidase B inhibitor | |||
| 0.063 | 0.055 | 0.063 | Potassium channel large-conductance Ca-activated activator | |||
| 0.027 | 0.019 | 0.027 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.046 | 0.039 | 0.046 | Dopamine beta hydroxylase inhibitor | |||
| 0.038 | 0.03 | 0.038 | Membrane dipeptidase inhibitor | |||
| 0.062 | 0.055 | 0.062 | Sirtuin 1 inhibitor | |||
| 0.042 | 0.035 | 0.042 | 5 Hydroxytryptamine 1A agonist | |||
| 0.042 | 0.035 | 0.042 | Histamine H1 receptor agonist | |||
| 0.018 | 0.012 | 0.018 | Aminopeptidase A inhibitor | |||
| 0.021 | 0.015 | 0.021 | Retinoid X beta receptor agonist | |||
| 0.11 | 0.104 | 0.11 | Histone deacetylase SIRT1 inhibitor | |||
| 0.105 | 0.099 | 0.105 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.013 | 0.007 | 0.013 | Beta 3 adrenoreceptor agonist | |||
| 0.037 | 0.032 | 0.037 | Dopamine D5 agonist | |||
| 0.126 | 0.121 | 0.126 | Dual specificity phosphatase 3 inhibitor | |||
| 0.026 | 0.02 | 0.026 | Nicotinic acid receptor 2 antagonist | |||
| 0.022 | 0.017 | 0.022 | Prostaglandin F2 alpha agonist | |||
| 0.018 | 0.013 | 0.018 | Endothelin B receptor antagonist | |||
| 0.022 | 0.017 | 0.022 | Beta 1 adrenoreceptor agonist | |||
| 0.084 | 0.079 | 0.084 | Protein kinase (CK2) inhibitor | |||
| 0.029 | 0.024 | 0.029 | Prostaglandin D2 agonist | |||
| 0.015 | 0.01 | 0.015 | Egl nine homolog 1 inhibitor | |||
| 0.064 | 0.06 | 0.064 | Benzodiazepine agonist | |||
| 0.09 | 0.085 | 0.09 | Alpha 2b adrenoreceptor antagonist | |||
| 0.078 | 0.074 | 0.078 | Estrogen-related receptor beta agonist | |||
| 0.027 | 0.023 | 0.027 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.083 | 0.079 | 0.083 | Glutamate release inhibitor | |||
| 0.008 | 0.004 | 0.008 | Integrin alpha5beta6 antagonist | |||
| 0.106 | 0.102 | 0.106 | Nav1.2 sodium channel blocker | |||
| 0.033 | 0.03 | 0.033 | 5-Alpha-reductase inhibitor | |||
| 0.018 | 0.015 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.048 | 0.046 | 0.064 | Protein kinase C eta inhibitor | 0.064 0.032 CID_124202110 | CID_124202110 | |
| 0.055 | 0.052 | 0.055 | Purinergic P2X1 antagonist | |||
| 0.141 | 0.139 | 0.141 | EphB2 antagonist | |||
| 0.013 | 0.011 | 0.013 | Somatostatin 2 agonist | |||
| 0.019 | 0.017 | 0.019 | Integrin beta5 antagonist | |||
| 0.029 | 0.027 | 0.029 | ATP citrate lysase inhibitor | |||
| 0.043 | 0.042 | 0.043 | Plasminogen activator inhibitor antagonist | |||
| 0.047 | 0.046 | 0.047 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.05 | 0.048 | 0.05 | Angiotensin-converting enzyme inhibitor | |||
| 0.043 | 0.042 | 0.043 | Metalloproteinase-3 inhibitor | |||
| 0.093 | 0.097 | 0.251 | Alkylator | 0.251 0.016 CID_124202110 | CID_124202110 | |
| 0.069 | 0.073 | 0.133 | Cell adhesion molecule inhibitor | 0.133 0.019 CID_124202110 | CID_124202110 | |
| 0.141 | 0.147 | 0.18 | Hypolipemic | 0.18 0.109 CID_124202110 | CID_124202110 | |
| 0.046 | 0.053 | 0.076 | Alpha-mannosidase inhibitor | 0.076 0.013 CID_124202110 | CID_124202110 | |
| 0.186 | 0.195 | 0.357 | Vasodilator, coronary | 0.357 0.052 CID_124202110 | CID_124202110 | |
| 0.029 | 0.042 | 0.035 | Protein kinase C beta I inhibitor | 0.035 0.019 CID_124202110 | CID_124202110 | |
| 0.035 | 0.052 | 0.072 | Mannosidase inhibitor | 0.072 0.011 CID_124202110 | CID_124202110 | |
| 0.107 | 0.128 | 0.116 | Mannose-6-phosphate isomerase inhibitor | 0.116 0.107 CID_124202110 | CID_124202110 | |
| 0.156 | 0.178 | 0.353 | Peptidyltransferase inhibitor | 0.353 0.012 CID_124202110 | CID_124202110 | |
| 0.11 | 0.137 | 0.275 | NOS3 expression enhancer | 0.275 0.022 CID_124202110 | CID_124202110 | |
| 0.184 | 0.213 | 0.504 | Immunosuppressant | 0.504 0.032 CID_124202110 | CID_124202110 | |
| 0.094 | 0.124 | 0.32 | Lipid peroxidase inhibitor | 0.32 0.016 CID_124202110 | CID_124202110 | |
| 0.051 | 0.084 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.095 0.036 CID_124202110 | CID_124202110 | |
| 0.012 | 0.052 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.005 CID_124202110 | CID_124202110 | |
| 0.104 | 0.148 | 0.193 | Hexokinase inhibitor | 0.193 0.04 CID_124202110 | CID_124202110 | |
| 0.068 | 0.118 | 0.087 | Thioredoxin inhibitor | 0.087 0.067 CID_124202110 | CID_124202110 | |
| 0.036 | 0.086 | 0.051 | Cytokine production stimulant | 0.051 0.026 CID_124202110 | CID_124202110 | |
| 0.093 | 0.161 | 0.175 | DNA repair enzyme inhibitor | 0.175 0.015 CID_124202110 | CID_124202110 | |
| 0.106 | 0.181 | 0.366 | Hepatoprotectant | 0.366 0.017 CID_124202110 | CID_124202110 | |
| 0.098 | 0.181 | 0.363 | Nitric oxide antagonist | 0.363 0.03 CID_124202110 | CID_124202110 | |
| 0.018 | 0.102 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.009 CID_124202110 | CID_124202110 | |
| 0.012 | 0.102 | 0.044 | Sodium/glucose cotransporter inhibitor | 0.044 0.006 CID_124202110 | CID_124202110 | |
| 0.009 | 0.1 | 0.049 | Sodium/glucose cotransporter 2 inhibitor | 0.049 0.007 CID_124202110 | CID_124202110 | |
| 0.024 | 0.116 | 0.105 | Protein 50S ribosomal subunit inhibitor | 0.105 0.012 CID_124202110 | CID_124202110 | |
| 0.042 | 0.139 | 0.063 | Lipocortins synthesis agonist | 0.063 0.031 CID_124202110 | CID_124202110 | |
| 0.048 | 0.148 | 0.236 | Topoisomerase I inhibitor | 0.236 0.019 CID_124202110 | CID_124202110 | |
| 0.03 | 0.132 | 0.072 | Glucose-6-phosphate translocase inhibitor | 0.072 0.015 CID_124202110 | CID_124202110 | |
| 0.154 | 0.263 | 0.243 | Caspase 3 stimulant | 0.243 0.118 CID_124202110 | CID_124202110 | |
| 0.037 | 0.158 | 0.083 | Adenine nucleotide translocase inhibitor | 0.083 0.008 CID_124202110 | CID_124202110 | |
| 0.063 | 0.184 | 0.182 | Toll-Like receptor 4 antagonist | 0.182 0.009 CID_124202110 | CID_124202110 | |
| 0.182 | 0.303 | 0.625 | Apoptosis agonist | 0.625 0.044 CID_124202110 | CID_124202110 | |
| 0.059 | 0.19 | 0.163 | Multidrug resistance-associated protein 1 inhibitor | 0.163 0.02 CID_124202110 | CID_124202110 | |
| 0.048 | 0.183 | 0.1 | DNA intercalator | 0.1 0.074 CID_124202110 | CID_124202110 | |
| 0.052 | 0.199 | 0.14 | DNA polymerase I inhibitor | 0.14 0.055 CID_124202110 | CID_124202110 | |
| 0.023 | 0.176 | 0.073 | Nitric oxide donor | 0.073 0.029 CID_124202110 | CID_124202110 | |
| 0.123 | 0.283 | 0.309 | Angiogenesis inhibitor | 0.309 0.088 CID_124202110 | CID_124202110 | |
| 0.019 | 0.185 | 0.168 | Antineoplastic antibiotic | 0.168 0.027 CID_124202110 | CID_124202110 | |
| 0.028 | 0.204 | 0.098 | Topoisomerase II alpha inhibitor | 0.098 0.041 CID_124202110 | CID_124202110 | |
| 0.018 | 0.202 | 0.048 | Microtubule stabilization | 0.048 0.031 CID_124202110 | CID_124202110 | |
| 0.039 | 0.225 | 0.091 | ATPase (Vacuolar H+) inhibitor | 0.091 0.055 CID_124202110 | CID_124202110 | |
| 0.115 | 0.308 | 0.473 | Alpha-glucosidase inhibitor | 0.473 0.088 CID_124202110 | CID_124202110 | |
| 0.084 | 0.285 | 0.338 | Vasodilator | 0.338 0.037 CID_124202110 | CID_124202110 | |
| 0.016 | 0.224 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.044 0.035 CID_124202110 | CID_124202110 | |
| 0.036 | 0.245 | 0.148 | Topoisomerase II inhibitor | 0.148 0.051 CID_124202110 | CID_124202110 | |
| 0.046 | 0.278 | 0.122 | Transcription factor NF kappa B stimulant | 0.122 0.024 CID_124202110 | CID_124202110 | |
| 0.022 | 0.271 | 0.074 | Factor IXa inhibitor | 0.074 0.018 CID_124202110 | CID_124202110 | |
| 0.063 | 0.313 | 0.144 | P-glycoprotein inhibitor | 0.144 0.126 CID_124202110 | CID_124202110 | |
| 0.091 | 0.391 | 0.138 | CC chemokine 6 receptor antagonist | 0.138 0.044 CID_124202110 | CID_124202110 | |
| 0.06 | 0.366 | 0.409 | Tumour necrosis factor alpha release inhibitor | 0.409 0.025 CID_124202110 | CID_124202110 | |
| 0.015 | 0.328 | 0.061 | Neuraminidase (influenza) inhibitor | 0.061 0.052 CID_124202110 | CID_124202110 | |
| 0.006 | 0.402 | 0.037 | Protein 30S ribosomal subunit inhibitor | 0.037 0.011 CID_124202110 | CID_124202110 | |
| 0.013 | 0.442 | 0.063 | Antibiotic Aminoglycoside-like | 0.063 0.008 CID_124202110 | CID_124202110 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |